As published in the Journal of Medical Physics, the NovaScan FastProbe was employed in a 350 patient study for the detection of breast cancer. NovaScan’s results were unparalled: 100% sensitivity and 85%+ specificity across 350 patients.
The NovaScan FastProbe device detects the presence of cancer, on or near the device, in 0.07 seconds. It is compact, and simple to operate. It also does not require capital equipment.
The NovaScan FastProbe is not cleared for sale in the United States.